Skip to main content
Clinical Trials/CTRI/2021/12/039020
CTRI/2021/12/039020
Completed
Phase 3

Efficacy of postoperative intravesical bupivacaineadministration in reducing catheter related bladder discomfort and postoperativelower urinary tract symptoms in patients following lower urinary tract transurethralelectrosurgery â?? A randomized double blinded placebo controlled trial

JIPMER0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: N399- Disorder of urinary system, unspecifiedHealth Condition 2: N398- Other specified disorders of urinary system
Sponsor
JIPMER
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 26, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
JIPMER

Eligibility Criteria

Inclusion Criteria

  • 1\.Subjects: All patients (aged \>\=18 years old) undergoing TURP or TURBT
  • 2\.American Society of Anesthesiologist physical status (ASA): I to III

Exclusion Criteria

  • 1\.Patients with residual tumor after resection of bladder tumor
  • 2\.Bladder perforation
  • 3\.Active hematuria
  • 4\.Patients exhibiting post operative delirium
  • 5\.Patients allergic to Bupivacaine or lidocaine
  • 6\.Cardiac conduction with partial or total block
  • 7\.Patient with progressive hepatic or renal impairment
  • 8\.Patient with class III anti\-arrhythmia agent(ex: amiodarone)
  • 9\.Patient with acute porphyria
  • 10\.Patients on corticosteroid therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials